Odeberg J, Söderberg-Nauclér C
Karolinska Institute, Division of Clinical Immunology, Huddinge Hospital, and Department of Biosciences, Novum, Stockholm, Sweden.
J Virol. 2001 Jun;75(11):5174-81. doi: 10.1128/JVI.75.11.5174-5181.2001.
After a primary infection, human cytomegalovirus (HCMV) establishes lifelong latency in myeloid lineage cells, and the virus has developed several mechanisms to avoid immune recognition and destruction of infected cells. In this study, we show that HCMV utilizes two different strategies to reduce the constitutive expression of HLA-DR, -DP, and -DQ on infected macrophages and that infected macrophages are unable to stimulate a specific CD4+ T-cell response. Downregulation of the HLA class II molecules was observed in 90% of the donor samples and occurred in two phases: at an early (1 day postinfection [dpi]) time point postinfection and at a late (4 dpi) time point postinfection. The early inhibition of HLA class II expression and antigen presentation was not dependent on active virus replication, since UV-inactivated virus induced downregulation of HLA-DR and inhibition of T-cell proliferation at 1 dpi. In contrast, the late effect required virus replication and was dependent on the expression of the HCMV unique short (US) genes US1 to -9 or US11 in 77% of the samples. HCMV-treated macrophages were completely devoid of T-cell stimulation capacity at 1 and 4 dpi. However, while downregulation of HLA class II expression was rather mild, a 66 to 90% reduction in proliferative T-cell response was observed. This discrepancy was due to undefined soluble factors produced in HCMV-infected cell cultures, which did not include interleukin-10 and transforming growth factor beta1. These results suggest that HCMV reduces expression of HLA class II molecules on HCMV-infected macrophages and inhibits T-cell proliferation by different distinct pathways.
原发性感染后,人巨细胞病毒(HCMV)在髓系细胞中建立终身潜伏感染,并且该病毒已发展出多种机制来避免免疫识别和破坏受感染细胞。在本研究中,我们发现HCMV利用两种不同策略来降低感染巨噬细胞上HLA-DR、-DP和-DQ的组成性表达,并且感染的巨噬细胞无法刺激特异性CD4+T细胞反应。在90%的供体样本中观察到HLA II类分子下调,且分两个阶段发生:感染后早期(感染后1天[dpi])时间点和感染后晚期(4 dpi)时间点。HLA II类表达和抗原呈递的早期抑制不依赖于活性病毒复制,因为紫外线灭活病毒在1 dpi时诱导HLA-DR下调并抑制T细胞增殖。相反,晚期效应需要病毒复制,并且在77%的样本中依赖于HCMV独特短(US)基因US1至-9或US11的表达。在1 dpi和4 dpi时,HCMV处理的巨噬细胞完全缺乏T细胞刺激能力。然而,虽然HLA II类表达下调相当轻微,但观察到增殖性T细胞反应降低了66%至90%。这种差异是由于HCMV感染的细胞培养物中产生的未定义可溶性因子所致,这些因子不包括白细胞介素-10和转化生长因子β1。这些结果表明,HCMV通过不同的独特途径降低HCMV感染巨噬细胞上HLA II类分子的表达并抑制T细胞增殖。